Dec. 10 (UPI) — Prescription drug prices in the United States are “unsustainable, unjustified and unfair,” according to a new 269-page report released on Friday by the House Oversight Committee.
Soaring drug prices have been a bipartisan issue and a long sore spot for consumers, particularly those with ongoing health issues. House Democrats, led by committee chair Rep. Carolyn Maloney, D-N.Y., said the report was culled from internal company documents and past Congressional hearings.
Republicans on the Oversight Committee released a competing review on Friday, laying the blame for high prices squarely on pharmacy benefit managers, or PBMs. The healthcare middlemen administer prescription drug plans for more than 266 million U.S. residents who have health insurance.
